PMID- 35342133
OWN - NLM
STAT- MEDLINE
DCOM- 20220603
LR  - 20231213
IS  - 1349-7235 (Electronic)
IS  - 0918-2918 (Print)
IS  - 0918-2918 (Linking)
VI  - 61
IP  - 11
DP  - 2022 Jun 1
TI  - Polymyalgia Rheumatica Following COVID-19 Vaccination.
PG  - 1775-1777
LID - 10.2169/internalmedicine.8934-21 [doi]
AB  - We herein report a 71-year-old woman presented with a fever, arthralgia, general 
      malaise and leg muscle stiffness following administration of the COVID-19 mRNA 
      vaccine (Comirnaty, Pfizer-BioNTech). Laboratory findings showed an elevated 
      C-reactive protein level and erythrocyte sedimentation rate. In addition, 
      Gallium-67 scintigraphy demonstrated an increased uptake in multiple joints. 
      Typing of human leukocyte antigen (HLA) revealed the presence of the 
      DRB1*0404/*0803 allele. These findings met the diagnostic criteria for 
      polymyalgia rheumatica (PMR), and when we started steroid treatment, her symptoms 
      improved rapidly. This patient developed PMR after receiving a COVID-19 mRNA 
      vaccine (Comirnaty, Pfizer-BioNTech). This case is considered to be valuable, as 
      the HLA-DRB1 allele was also confirmed.
FAU - Yokote, Akira
AU  - Yokote A
AD  - Department of Neurology, Fukuoka University School of Medicine, Japan.
FAU - Fujioka, Shinsuke
AU  - Fujioka S
AD  - Department of Neurology, Fukuoka University School of Medicine, Japan.
FAU - Takahashi, Nobutaka
AU  - Takahashi N
AD  - Department of Neurology, Fukuoka University School of Medicine, Japan.
FAU - Mishima, Takayasu
AU  - Mishima T
AD  - Department of Neurology, Fukuoka University School of Medicine, Japan.
FAU - Tsuboi, Yoshio
AU  - Tsuboi Y
AD  - Department of Neurology, Fukuoka University School of Medicine, Japan.
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20220326
PL  - Japan
TA  - Intern Med
JT  - Internal medicine (Tokyo, Japan)
JID - 9204241
RN  - 0 (COVID-19 Vaccines)
RN  - 0 (Vaccines, Synthetic)
RN  - 0 (mRNA Vaccines)
SB  - IM
MH  - Aged
MH  - *COVID-19/prevention & control
MH  - *COVID-19 Vaccines/adverse effects
MH  - Female
MH  - Giant Cell Arteritis/diagnosis
MH  - Humans
MH  - *Polymyalgia Rheumatica/diagnosis/drug therapy
MH  - Vaccination
MH  - Vaccines, Synthetic
MH  - mRNA Vaccines
PMC - PMC9259323
OTO - NOTNLM
OT  - COVID-19
OT  - polymyalgia rheumatica
OT  - vaccination
COIS- The authors state that they have no Conflict of Interest (COI).
EDAT- 2022/03/29 06:00
MHDA- 2022/06/07 06:00
PMCR- 2022/06/01
CRDT- 2022/03/28 05:30
PHST- 2022/03/29 06:00 [pubmed]
PHST- 2022/06/07 06:00 [medline]
PHST- 2022/03/28 05:30 [entrez]
PHST- 2022/06/01 00:00 [pmc-release]
AID - 10.2169/internalmedicine.8934-21 [doi]
PST - ppublish
SO  - Intern Med. 2022 Jun 1;61(11):1775-1777. doi: 10.2169/internalmedicine.8934-21. 
      Epub 2022 Mar 26.